The Efficacy of Structural Ecosystems Therapy for HIV Medication Adherence with African American Women

Overview

Journal J Fam Psychol

Publisher American Psychological Association

Specialty Psychology

Date 2010 Feb 24

PMID 20175608

Citations 13

Authors

Daniel J Feaster

Ahnalee M Brincks

Victoria B Mitrani

Guillermo Prado

Seth J Schwartz

Jose Szapocznik

Affiliations

Soon will be listed here.

Abstract

A systemic family therapy intervention, Structural Ecosystems Therapy (SET; Mitrani, Szapocznik, & Robinson-Batista, 2000; Szapocznik et al., 2004), has been shown to promote adaptation to living with HIV by reducing psychological distress and family hassles. This investigation examines the effect of SET on HIV medication adherence relative to a person-centered condition and a community control condition. Medication adherence was assessed on 156 trial participants. Results of a 2-part model showed that SET was significantly more likely to move women to high levels of adherence (defined as at least 95% adherence) than a person-centered therapy. Family hassles were also significantly reduced by SET, though the effect of SET on medication adherence did not appear related to this change in family hassles.

Citing Articles

Examining stigma, social support, and gender differences in unsuppressed HIV viral load among participants in HPTN 065.

Maragh-Bass A, Gamble T, El-Sadr W, Hanscom B, Tolley E J Behav Med. 2020; 44(2):159-171.

PMID: 33161564 PMC: 11068030. DOI: 10.1007/s10865-020-00186-7.

Pilot Randomized Controlled Trial of a Syndemics Intervention with HIV-Positive, Cocaine-Using Women.

Jemison D, Jackson S, Oni O, Cats-Baril D, Thomas-Smith S, Batchelder A AIDS Behav. 2019; 23(9):2467-2476.

PMID: 31407212 PMC: 6880306. DOI: 10.1007/s10461-019-02625-2.

Strategies for improving the lives of US women aged 40 and above living with HIV/AIDS: an evidence map.

Adam G, Di M, Cu-Uvin S, Halladay C, Smith B, Iyer S Syst Rev. 2018; 7(1):25.

PMID: 29391059 PMC: 5796491. DOI: 10.1186/s13643-018-0684-y.

Psychosocial group interventions to improve psychological well-being in adults living with HIV.

van der Heijden I, Abrahams N, Sinclair D Cochrane Database Syst Rev. 2017; 3:CD010806.

PMID: 28291302 PMC: 5461871. DOI: 10.1002/14651858.CD010806.pub2.

Challenges in the Evaluation of Interventions to Improve Engagement Along the HIV Care Continuum in the United States: A Systematic Review.

Risher K, Kapoor S, Daramola A, Paz-Bailey G, Skarbinski J, Doyle K AIDS Behav. 2017; 21(7):2101-2123.

PMID: 28120257 PMC: 5843766. DOI: 10.1007/s10461-017-1687-8.

References

McDavid K, Li J, Lee L . Racial and ethnic disparities in HIV diagnoses for women in the United States. J Acquir Immune Defic Syndr. 2006; 42(1):101-7. DOI: 10.1097/01.qai.0000199353.11479.08. View

S Ingersoll K, Heckman C . Patient-clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav. 2005; 9(1):89-101. PMC: 2868061. DOI: 10.1007/s10461-005-1684-1. View

Dunbar P, Madigan D, Grohskopf L, Revere D, Woodward J, Minstrell J . A two-way messaging system to enhance antiretroviral adherence. J Am Med Inform Assoc. 2003; 10(1):11-5. PMC: 150355. DOI: 10.1197/jamia.m1047. View

Crepaz N, Lyles C, Wolitski R, Passin W, Rama S, Herbst J . Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006; 20(2):143-57. DOI: 10.1097/01.aids.0000196166.48518.a0. View

DeMasi R, Graham N, Tolson J, Pham S, Capuano G, Fisher R . Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Adv Ther. 2001; 18(4):163-73. DOI: 10.1007/BF02850110. View

Wei L, Lachin J . Properties of the urn randomization in clinical trials. Control Clin Trials. 1988; 9(4):345-64. DOI: 10.1016/0197-2456(88)90048-7. View

Walsh J, Mandalia S, Gazzard B . Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002; 16(2):269-77. DOI: 10.1097/00002030-200201250-00017. View

Rathbun R, Farmer K, Stephens J, Lockhart S . Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther. 2005; 27(2):199-209. DOI: 10.1016/j.clinthera.2005.02.010. View

Cole S, Hernan M, Anastos K, Jamieson B, Robins J . Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol. 2007; 166(2):219-27. DOI: 10.1093/aje/kwm047. View

10.

Parsons J, Golub S, Rosof E, Holder C . Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007; 46(4):443-50. PMC: 2666542. DOI: 10.1097/qai.0b013e318158a461. View

11.

Simoni J, Kurth A, Pearson C, Pantalone D, Merrill J, Frick P . Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006; 10(3):227-45. PMC: 4083461. DOI: 10.1007/s10461-006-9078-6. View

12.

Amico K, Harman J, Johnson B . Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006; 41(3):285-97. DOI: 10.1097/01.qai.0000197870.99196.ea. View

13.

Singh N, Berman S, Swindells S, Justis J, Mohr J, Squier C . Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999; 29(4):824-30. DOI: 10.1086/520443. View

14.

Remien R, Stirratt M, Dognin J, Day E, El-Bassel N, Warne P . Moving from theory to research to practice. Implementing an effective dyadic intervention to improve antiretroviral adherence for clinic patients. J Acquir Immune Defic Syndr. 2006; 43 Suppl 1:S69-78. DOI: 10.1097/01.qai.0000248340.20685.7d. View

15.

Safren S, Hendriksen E, DeSousa N, Boswell S, Mayer K . Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. 2003; 15(6):787-93. DOI: 10.1080/09540120310001618630. View

16.

Harrigan P, Hogg R, Dong W, Yip B, Wynhoven B, Woodward J . Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005; 191(3):339-47. DOI: 10.1086/427192. View

17.

Beach M, Keruly J, Moore R . Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?. J Gen Intern Med. 2006; 21(6):661-5. PMC: 1924639. DOI: 10.1111/j.1525-1497.2006.00399.x. View

18.

Rotheram-Borus M, Flannery D, Rice E, Lester P . Families living with HIV. AIDS Care. 2005; 17(8):978-87. DOI: 10.1080/09540120500101690. View

19.

Simoni J, Pantalone D, Plummer M, Huang B . A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007; 26(4):488-95. PMC: 4044097. DOI: 10.1037/0278-6133.26.4.488. View

20.

Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View